Agriculture
A2 Milk Unveils $300 Million Shareholder Payout
The dairy company announced a $300 million special dividend after receiving regulatory clearance in China, a milestone that finalises its Pokeno acquisition and paves the way for increased shareholder returns.
The A2 Milk Company will repay NZ$300 million to its shareholders following obtaining regulatory approval in China for two infant formula registrations for products associated with its Pōkeno manufacturing plant in New Zealand.
The approval eliminates the last condition imposed on a capital management plan announced in 2025 after the Pōkeno facility was acquired and the company's share in Mataura Valley Milk sold. The special dividend is expected to be paid in July 2026.
The registrations are mandatory for infant formula products offered in China's domestic market and are considered a crucial element of the firm's supply chain plans in its biggest market.
In 2000, Dr Corrie McLachlan and Howard Paterson established A2 Milk in Auckland, with the aim of developing a global business of Milk derived from cows that naturally only produce the A2 BETA-CASEIN protein. It produces fresh milk, infant formula, nutritional products, ingredients and licensing; and has operations in Australia, New Zealand, China, other Asian countries and the United States.
China Market Drives Growth
China continues to be the company's biggest revenue generator and the hub of its infant nutrition company.
A2 Milk took in NZ$993.5 million in the six months leading to the end of 2025, reflecting a 18.8% year-over-year increase in revenue. Net profit after tax increased 9.4% to NZ$112.1 million.
China and other Asian markets contributed NZ$739 million in revenue, an increase of 20.3% from the prior period, which represents over 70% of the group's sales. Australia and New Zealand accounted for revenue of NZ$171.3 million, and the United States NZ$83.2 million.
Approval Completes Key Transaction
The acquisition of the Pōkeno facility happened in September 2025 and the two China label infant formula registrations will be included.
The newest approval will enable the firm to move forward with products linked to those registrations and wrap up one of the essentials of the transaction. That process would determine the dividend.
The company was well placed to cover the special dividend, with cash and short-term deposits of around NZ$897 million at the end of the first half of FY2026.
Strong Financial Position
The a2 Milk reported revenue of around NZ$1.9 billion and net profit of NZ$202.9 million for FY25. The company's biggest product group, infant formula, has been supporting profits despite general demographic trends in the Chinese dairy industry.
The NZ$300 million special dividend is one of the largest capital returns made by the company and comes after a string of positive earnings, solid cash generation and regulatory milestones relating to the company's China activities.
Source: Capital Brief
Follow Inspirepreneur Magazine for daily global business news.